Whitehawk Therapeutics, Inc.
Develops advanced antibody-drug conjugates (ADCs) for difficult-to-treat cancers.
WHWK | US
Overview
Corporate Details
- ISIN(s):
- US00032Q1040 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 2 HEADQUARTERS PLAZA, 7960 MORRISTOWN
- Website:
- https://ir.whitehawktx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Whitehawk Therapeutics, Inc. is a preclinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to develop improved cancer treatments. The company's core focus is its portfolio of three advanced antibody-drug conjugates (ADCs), which are engineered to overcome the limitations of first-generation predecessors and target difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive global development and commercialization agreement. Formerly known as Aadi Bioscience, the company relaunched as Whitehawk Therapeutics to signify its strategic evolution into an ADC-focused enterprise.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Whitehawk Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Whitehawk Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Whitehawk Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
